Georgian Partners leads $35 mln Series C financing of Glooko
Glooko, a U.S. diabetes data management platform, has secured US$35 million in a Series C financing. The round was led by Canadian growth equity firm Georgian Partners and joined by new and existing investors, including Canaan Partners, Medtronic and Social Capital. Founded in 2010, Glooko is a developer of remote patient monitoring technology. It currently helps more than one million patients served by 6,000 providers in 27 countries. The Mountain View, California-based company plans to use the funds raised to expand market access and deepen its expertise in data analytics.
27 June 2017•3 mins read
